Log in to search using one of your social media accounts:

 

Opioids now kill more people than breast cancer
More than 63,600 lives were lost to drug overdose in 2016, the most lethal year yet of the drug overdose epidemic, according to a new report from the National Center for Health Statistics, part of the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - December 21, 2017 Category: Consumer Health News Source Type: news

New marker could detect fatal breast cancer up to one year earlier than current methods
(BioMed Central) A new marker that could be used to diagnose fatal breast cancer up to one year ahead of current methods has been described in a study published in the open access journal Genome Medicine this week. A team of researchers led by University College London, UK found that a region of DNA called EFC#93 showed abnormal patterns of DNA methylation in breast cancer samples. Importantly, these patterns are present in blood serum before the cancer becomes detectable in the breast. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 21, 2017 Category: Cancer & Oncology Source Type: news

G-quadruplex regulates breast cancer-associated gene
(Baylor College of Medicine) For breast cancer, carrying protein CD44s, instead of CD44v, has a survival advantage. Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 21, 2017 Category: Cancer & Oncology Source Type: news

Researchers map molecular interaction that prevents aggressive breast cancer
(Rockefeller University Press) Researchers in Italy have discovered how specific versions of a protein called Numb protect the key tumor suppressor p53 from destruction. The study, which will be published Dec. 21 in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 21, 2017 Category: Cancer & Oncology Source Type: news

Why Is Neoadjuvant Endocrine Therapy Underused in Breast Cancer? Why Is Neoadjuvant Endocrine Therapy Underused in Breast Cancer?
Experts discuss the evidence behind neoadjuvant endocrine therapy for early-stage breast cancer and obstacles to wider use of this treatment strategy.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

A systematic review of alcohol interventions for people living with and beyond cancer
Conclusion This review highlights there is a lack of interventions which have a specific focus on reducing how much alcohol people are drinking following a diagnosis for cancer.  Alcohol use can increase the risk of secondary or recurrent cancer, especially in people who have been diagnosed with breast cancer, and head and neck cancers. Therefore, there is a need for more research to explore the potential for interventions to encourage people who have been diagnosed with cancer to drink less alcohol, which can reduce this risk. Further Information Contact details for corresponding author: Dr Grant J. McGeechan, C1.1...
Source: Alcohol Research UK - December 20, 2017 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

Medical News Today: Can an existing drug win against aggressive breast cancer?
A cytokine used to treat autoimmune diseases such as multiple sclerosis may be the new weapon in the fight against triple-negative breast cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 20, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

‘Drugs are too expensive for the NHS – and people are paying with their lives’ | Robert Hart
Don ’t blame the NHS for denying vital medication, say members of a new activist group, Just Treatment. Blame the pharma companies hooked on huge profitsArms aloft, activist and breast cancer patient Emma Robertson emerged from the UK headquarters ofpharmaceutical giant Pfizer last month wearing a bright blue T-shirt. Emblazoned on the back in bold yellow letters were the words: “No drug should ever cost a life”.Related:Cancer drug companies cut prices to win NHS approvalContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 20, 2017 Category: Science Authors: Robert Hart Tags: Drugs Society Pharmaceuticals industry Business Science Cancer Health Cancer research Medical research NHS Activism UK news Source Type: news

AI can spot large pneumothoraces on chest x-ray
Artificial intelligence (AI) algorithms can automatically detect large pneumothoraces...Read more on AuntMinnie.comRelated Reading: Top 5 trends from RSNA 2017 in Chicago Artificial intelligence shows promise for breast cancer metastases Is seeing believing in imaging artificial intelligence? Video from RSNA 2017: How will AI change radiology? Can AI diagnose pneumonia better than radiologists? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 20, 2017 Category: Radiology Source Type: news

Puberty in Girls by Breast Cancer Family History Puberty in Girls by Breast Cancer Family History
Are pubertal milestones altered in girls who have a family history of breast cancer?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

FDA Approves Genentech ’s Perjeta (Pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer
South San Francisco, CA -- December 20, 2017 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Perjeta ® (pertuzumab), in combination with Herceptin®... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 20, 2017 Category: Drugs & Pharmacology Source Type: news

CT scans of Egyptian mummies reveal oldest known cases of breast cancer and multiple myeloma
(University of Granada) An international research team has established that the woman with breast cancer died around 2000 B.C., while the man with multiple myeloma died around 1800 B.C. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 20, 2017 Category: International Medicine & Public Health Source Type: news

South Korea's Samsung Bioepis says FDA to review Herceptin copy
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Wednesday the U.S. Food and Drug Administration (FDA) has accepted for review its copy of Swiss drugmaker Roche's blockbuster breast cancer drug Herceptin for potential approval. (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New AJCC Breast Cancer Prognostic Stage vs Anatomic Stage New AJCC Breast Cancer Prognostic Stage vs Anatomic Stage
Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 19, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Breast cancer risk remains in newer versions of contraceptive pill
Women taking the pill or other hormonal contraception face a 20% higher risk of breast cancer than those not using this type of birth control, according to new research. (Source: Nursing Times)
Source: Nursing Times - December 19, 2017 Category: Nursing Source Type: news

Too Many Older Patients Get Cancer Screenings
Older patients are often aggressively screened for cancer, even if they won ’ t live long enough to benefit. (Source: NYT Health)
Source: NYT Health - December 19, 2017 Category: Consumer Health News Authors: LIZ SZABO, KAISER HEALTH NEWS Tags: Tests (Medical) Mammography Prostate Gland Prostate Cancer Breast Cancer Elderly Skin Age, Chronological Anxiety and Stress Health Insurance and Managed Care Colonoscopy Source Type: news

Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
RIJSWIJK, Netherlands and IRVINE, California and AMSTERDAM, December 19, 2017 -- (Healthcare Sales & Marketing Network) -- Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and mole... Diagnostics, Personalized Medicine, Oncology, Product Launch Bluebee, Agendia, MammaPrint, Breast Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2017 Category: Pharmaceuticals Source Type: news

Top Breast Cancer News of 2017
(Source: CancerNetwork)
Source: CancerNetwork - December 19, 2017 Category: Cancer & Oncology Authors: Cancer Network Editors Tags: Breast Cancer Breast Cancer Year in Review 2017 Source Type: news

Prostate diagnosis shame: Men wait four times as long
It takes 56 days, on average, from the time a man reports symptoms to a GP, for him to be confirmed with prostate cancer - whereas women are told they have breast cancer after 14 days. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2017 Category: Consumer Health News Source Type: news

Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT
The precursor homocysteine is metabolized either through the methionine cycle to produce methionine or through the transsulfuration pathway to synthesize cysteine. Alternatively, cysteine can be obtained through uptake of its oxidized form, cystine. Many cancer cells exhibit methionine dependency such that their proliferation is impaired in growth media in which methionine is replaced by homocysteine. We showed that oncogenic PIK3CA and decreased expression of SLC7A11, a gene that encodes a cystine transporter also known as xCT, correlated with increased methionine dependency in breast cancer cells. Oncogenic PIK3CA was su...
Source: Signal Transduction Knowledge Environment - December 19, 2017 Category: Science Authors: Lien, E. C., Ghisolfi, L., Geck, R. C., Asara, J. M., Toker, A. Tags: STKE Research Articles Source Type: news

Medical tyranny: Woman who rejected breast cancer diagnosis may still be forced undergo surgery without her consent
(Natural News) When a doctor suggests an operation that you don’t feel is necessary, you have the right to decide not to move forward with it – right? If you happen to have any sort of mental illness, it’s something that doctors could use to say you’re not in your right mind to make such... (Source: NaturalNews.com)
Source: NaturalNews.com - December 18, 2017 Category: Consumer Health News Source Type: news

ctDNA Testing'Could Help Prevent Breast Cancer Relapses'ctDNA Testing'Could Help Prevent Breast Cancer Relapses '
The threat of breast cancer recurrence could soon be averted by offering women additional treatment in advance of their relapse, thanks to the latest circulating tumor DNA assays, says a UK expert.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UCLA senior delivers digital health monitoring to fight disease in Cameroon
As Vikash Singh looks forward to 2018 he is also looking forward to witnessing his education in action. Specifically how his background in medical research, artificial intelligence and machine learning — along with a $5,000UCLA Global Citizens Fellowship award and some innovative thinking — may potentially help save lives in Cameroon.Doctors at the HSPC Polyclinic in Kumba, a city located in the country ’s southwest region, will soon begin uploading patient information to a software application designed by Singh and a team of student programmers through Project DataReach, a company Singh launched in 2015 ...
Source: UCLA Newsroom: Health Sciences - December 18, 2017 Category: Universities & Medical Training Source Type: news

GnRH Analogue Use Preserves Fertility During Chemotherapy GnRH Analogue Use Preserves Fertility During Chemotherapy
Meta-analysis confirms that the use of a GnRH analogue during chemotherapy helps preserve ovarian function and fertility in young women undergoing treatment for early breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast Pain Uncommon Symptom of Breast Cancer Breast Pain Uncommon Symptom of Breast Cancer
Breast pain is not often a symptom of breast cancer regardless of age, and mostly women need to be reassured that breast pain is both common and benign.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Simplified Surgery Reduces Lymphedema Risk After ALND Simplified Surgery Reduces Lymphedema Risk After ALND
Simplified surgical technique greatly reduces the risk for postoperative lymphedema following axillary lymph node dissection and breast cancer surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Powerful Trend': Chemo Use for Breast Cancer Drops'Powerful Trend': Chemo Use for Breast Cancer Drops
Between 2013 and 2015, the use of chemotherapy in early-stage breast cancer in the United States sharply decreased, according to a study.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 18, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Researchers repurpose immune-activating cytokine to fight breast cancer
The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine. In the Proceedings of the National Academy of Sciences, researchers showed triple-negative breast cancer cells are highly vulnerable to interferon-β - a potent antimicrobial that also activates the immune system. The new study shows interferon-β impairs breast cancer cells' ability to migrate and form tumors. (Source: World Pharma News)
Source: World Pharma News - December 18, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

A New PARP Drug For Breast Cancer? I'm Thrilled!
The paradigm for using chemo first to treat advanced breast cancer may change, as we gain experience with these new drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 18, 2017 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:PFE NYSE:AZN NASDAQ:TSRO NASDAQ:CLVS Source Type: news

Why I'm Thrilled About A New PARP Drug For Breast Cancer
The paradigm for using chemo first to treat advanced breast cancer may change, as we gain experience with these new drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 18, 2017 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:PFE NYSE:AZN NASDAQ:TSRO NASDAQ:CLVS Source Type: news

Lapatinib With Foretinib in HER2+ Metastatic Breast Cancer Lapatinib With Foretinib in HER2+ Metastatic Breast Cancer
Early research finds limited activity with the combination of lapatinib and foretinib for advanced HER2+ breast cancer.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Germline Genetics and Decision Making in Breast Cancer Germline Genetics and Decision Making in Breast Cancer
Patients with breast cancer often undergo genetic testing without seeing a genetic counselor. Does this affect their treatment decisions?Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo
(American Association for Cancer Research) The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2017 Category: International Medicine & Public Health Source Type: news

Researchers repurpose immune-activating cytokine to fight breast cancer
(Case Western Reserve University) The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center. In PNAS, researchers showed triple-negative breast cancer cells are highly vulnerable to interferon-β -- a potent antimicrobial that also activates the immune system. The new study shows interferon-β impairs breast cancer cells' ability to migrate and form tumors. The study also suggests interferon-β treatment could improve outcomes for certain breast cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 18, 2017 Category: Cancer & Oncology Source Type: news

NHS to fund new specialised treatments
Some 3,000 patients with HIV, genetic conditions and skin disorders will benefit Related items fromOnMedica Work needed to boost GPs ’ knowledge of cancer drug Ovarian cancer drug may help stall breast cancer NHS launches mass HIV prevention trials World AIDS Day: The fight against HIV Stevens-Johnson syndrome and toxic epidermal necrolysis (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 18, 2017 Category: UK Health Source Type: news

JACQUIE BELTRAO on her tamoxifen living hell
Tamoixifen might be a lifesaver for breast cancer patients, but it's irritating side effects, such as late night hot flushes, are absolutely awful, writes Sky News' JACQUIE BELTRAO. (Source: the Mail online | Health)
Source: the Mail online | Health - December 17, 2017 Category: Consumer Health News Source Type: news

New Cancer Drug Shows Promise Against Wide Range of Tumors
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 16, 2017 Category: Cancer & Oncology Source Type: news

Women don't know about breast cancer treatment options
Many women don't feel completely informed about their surgical options for...Read more on AuntMinnie.comRelated Reading: Contrast US helps assess breast cancer treatment response Breast cancer treatment varies in cost-effectiveness DBT reduces breast surgery re-excision rates Clinical trials to shed new light on preoperative breast MRI Imaging tool could reduce repeat breast cancer surgeries (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news

Medical News Today: Breast cancer: These gene variations may shorten young women's survival
New research finds that young women with early-onset breast cancer possess variations in a specific gene that might affect their survival. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 15, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Exercise Proven, but Underused, for Breast Cancer Fatigue Exercise Proven, but Underused, for Breast Cancer Fatigue
Despite the fact that studies have consistently shown that exercise reduces breast cancer fatigue, many physicians do not discuss exercise programs with their breast cancer patients.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

New Potential Drug Therapy for AI-Associated Arthralgia New Potential Drug Therapy for AI-Associated Arthralgia
The anti-depressant duloxetine effectively reduced musculoskeletal symptoms early in the course of treatment with aromatase inhibitors for early-stage breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Women overestimate breast cancer risk, prefer biopsy
Most women tend to overestimate their risk of breast cancer, according to research...Read more on AuntMinnie.comRelated Reading: At-risk women not receiving breast MRI scans Mammo recalls don't keep women from other tests Most women prefer annual breast cancer screening Women still value mammography's benefits over 'harms' Simple interventions reduce mammography recall rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news

Aspirin, NSAIDs and Prospective Risk of HER2+ Breast Cancer Aspirin, NSAIDs and Prospective Risk of HER2+ Breast Cancer
Does aspirin or ibuprofen reduce risk of HER2+ breast cancer?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Many women report not feeling completely informed about breast cancer treatment options
(American College of Surgeons) Results from two separate studies in the Journal of the American College of Surgeons showed a decision aid tool may help mitigate the sense of urgency patients feel about making treatment decisions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2017 Category: International Medicine & Public Health Source Type: news

Journalists can register now to attend the European Breast Cancer Conference (EBCC-11)
(ECCO-the European CanCer Organisation) Journalists can register now to attend the European Breast Cancer Conference (EBCC-11), which takes place in Barcelona, Spain, Wednesday 21 to Friday 23 March 2018. Registration for media is free. Europe's most exciting international cancer conference is the only one to involve all the major players in breast cancer. Scientists, clinicians, patient representatives and policy makers will discuss the latest scientific advances, and also the ethical, social, political, and practical issues associated with caring for patients with breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2017 Category: International Medicine & Public Health Source Type: news

New Technology Can Help Detect Breast Cancer In Some Women
BOSTON (CBS) – More than 40% of women in the United States have dense breasts which can make it hard to find small cancers on a mammogram, but researchers are testing a new technology that could help. It is a 3-dimensional ultrasound called SoftVue. During the exam, the patient lies on her stomach, and her breast is placed into a warm water bath. In two to four minutes, the machine creates a 3D image using sound waves. SoftVue exam (WBZ-TV) There is no radiation and no compression of the breast. While SoftVue probably would not replace a woman’s annual mammogram, it might be used in conjunction with mammography...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 14, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Breast Cancer Health Local News Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Source Type: news

Light & #039;Em Up: S & amp;N & #039;s Device Images Bacteria in Wounds
Smith & Nephew has begun selling a handheld imaging device that can detect bacteria in hard-to-heal wounds and instantly measure wound surface area. MolecuLight i:X is already available in Canada, where its inventor stumbled across the idea for the device. Ralph DaCosta, MD, now a principal investigator at Princess Margaret Cancer Center in Toronto, was a PhD student researching fluorescent imaging of gastrointestinal cancer in 2007. The big, expensive device he was using didn’t produce any green images, which would have indicated cancer, but a red image that he couldn’t identify. DaCosta took a photo of t...
Source: MDDI - December 14, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: Imaging Source Type: news

Many With Early Breast Cancer Are Skipping Chemo
Fewer women with early stage breast cancer are turning to chemotherapy to fight their disease, a new study finds. (Source: WebMD Health)
Source: WebMD Health - December 14, 2017 Category: Consumer Health News Source Type: news

Bristol mother-of-three receives a Christmas miracle
Heidi Loughlin, 35, from Bristol, said the world is her oyster after defying the death sentence imposed on her by doctors. She was diagnosed with a rare and aggressive breast cancer in 2015. (Source: the Mail online | Health)
Source: the Mail online | Health - December 14, 2017 Category: Consumer Health News Source Type: news

Mother-of-three, 35, receives a Christmas miracle
Heidi Loughlin, 35, from Bristol, said the world is her oyster after defying the death sentence imposed on her by doctors. She was diagnosed with a rare and aggressive breast cancer in 2015. (Source: the Mail online | Health)
Source: the Mail online | Health - December 14, 2017 Category: Consumer Health News Source Type: news